Drawing for EVIVE BIOTECH

USPTO serial 79299060

EVIVE BIOTECH

Reviewed by CopyMark Law Group

Reg. 6610178Status 700Registered
Filing date
Status date
Registration date
Jan 11, 2022
Examiner
LEASER, ANDREW C
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EVIVE BIOTECH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals for the treatment of infectious disease and for use in oncology; medical and veterinary preparations, namely, preparations for the treatment of infectious disease and for use in oncology, diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans, pharmaceutical preparations for use in chemotherapy, pharmaceutical products for the prevention and treatment of cancer, pharmaceutical preparations for the treatment of viral infections and diseases, and antibacterial pharmaceuticals; pharmaceutical preparations for health care, namely, anti-inflammatory preparations, antipyretic preparations, biological preparations for the treatment of cancer, mixed biological preparations for the treatment and prevention of infectious diseasesACTIVE
010Apparatus for medical use, namely, insulin pumps, insulin injectors sold empty, medical fluid injectorsACTIVE
042Research and development services relating to medicines; medical laboratory services; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; design of medical apparatus for others; biotechnology research; research relating to pharmaceuticalsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 18, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jun 24, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Jun 24, 2022FIMPFINAL DISPOSITION PROCESSED
Apr 11, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 11, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 26, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 26, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 6, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 18, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2021XAECEXAMINER'S AMENDMENT ENTERED
Sep 18, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 18, 2021GNEAEXAMINERS AMENDMENT E-MAILED
Sep 18, 2021CNEAEXAMINERS AMENDMENT -WRITTEN
Aug 19, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 18, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 18, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 13, 2021RFNTREFUSAL PROCESSED BY IB
Mar 22, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 22, 2021RFRRREFUSAL PROCESSED BY MPU
Mar 21, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 20, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 13, 2021DOCKASSIGNED TO EXAMINER
Mar 5, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB
Dec 8, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Dec 4, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 3, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance